These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 18087788)
1. [Drug industry's "offers" to health personnel]. Møller N Ugeskr Laeger; 2007 Nov; 169(47):4081. PubMed ID: 18087788 [No Abstract] [Full Text] [Related]
2. [Drug information must be critically scrutinized. Industry's only wish: prescription from the physician to the patient]. Liedholm H; Linné AB Lakartidningen; 2001 Apr; 98(16):1892-7. PubMed ID: 11370405 [TBL] [Abstract][Full Text] [Related]
4. Educating health professionals about drug and device promotion: a Nepalese perspective. Shankar PR PLoS Med; 2007 Feb; 4(2):e89; author reply e88. PubMed ID: 17326721 [No Abstract] [Full Text] [Related]
5. [The pharmaceutical consultant plays a principal role in the industry's information]. Klein S Nord Med; 1978 Apr; 93(3-4):84-5. PubMed ID: 643538 [No Abstract] [Full Text] [Related]
6. Is drug advertising informing the consumer? Hanlon PM Behav Healthc Tomorrow; 2002 Feb; 11(1):SR35-7. PubMed ID: 11837141 [No Abstract] [Full Text] [Related]
7. US drug industry's guidelines on advertising too limited, say critics. Burton B BMJ; 2005 Aug; 331(7514):420. PubMed ID: 16110059 [No Abstract] [Full Text] [Related]
8. [Physicians notify on drug industry's marketing]. Perman E Lakartidningen; 2004 Mar; 101(11):1014-5. PubMed ID: 15055124 [No Abstract] [Full Text] [Related]
9. The pharmaceutical industry and disease mongering. Will industry's latest moves promote public health or private profit? McKechnie S BMJ; 2002 Jul; 325(7357):216; author reply 216. PubMed ID: 12143862 [No Abstract] [Full Text] [Related]
11. Four drug companies breach industry's code of practice. Hawkes N BMJ; 2010 Dec; 341():c7266. PubMed ID: 21163846 [No Abstract] [Full Text] [Related]
12. Open access to industry's clinically relevant data. Herxheimer A BMJ; 2004 Jul; 329(7457):64-5. PubMed ID: 15242886 [No Abstract] [Full Text] [Related]
13. [Information from drug producers]. Oye I Tidsskr Nor Laegeforen; 1977 May; 97(13):654-6. PubMed ID: 867358 [No Abstract] [Full Text] [Related]
14. [Misuse of literature references in advertising]. Jørgen E Ugeskr Laeger; 2004 Nov; 166(48):4393; author reply 4393-4. PubMed ID: 15587640 [No Abstract] [Full Text] [Related]
15. Sales reps: footsoldiers in drug company wars. Prescrire Int; 2004 Jun; 13(71):116. PubMed ID: 15233155 [No Abstract] [Full Text] [Related]
16. New inconvenient trend in advertising medicine. Salunke AZ J Indian Med Assoc; 1994 Nov; 92(11):381. PubMed ID: 7890949 [No Abstract] [Full Text] [Related]
17. Promoting and advertising therapeutic goods. Trade Practices Commission report on self-regulation. Moulds RF Med J Aust; 1992 Oct; 157(8):513-4. PubMed ID: 1479969 [No Abstract] [Full Text] [Related]
18. [Drug information: a company convicted for advertising without permission from the Medical Products Agency]. Lakartidningen; 1997 Feb; 94(6):449. PubMed ID: 9053698 [No Abstract] [Full Text] [Related]
19. [Central management of all drug information? Information of industries should be decreased strongly. There should be fewer consultants and they should be given a new role]. Karlsson Y Nord Med; 1977 Nov; 92(11):284-5. PubMed ID: 917783 [No Abstract] [Full Text] [Related]
20. [Consumer drug advertising has negative effects on the patient-physician relationship]. Andersén Karlsson E; Hedman P Lakartidningen; 2004 Jun; 101(24):2078-9. PubMed ID: 15282982 [No Abstract] [Full Text] [Related] [Next] [New Search]